Cargando…

Prognostic relevance of demographic factors in cardiac magnetic resonance-proven acute myocarditis: A cohort study

AIM: Acute myocarditis (AM) is a heterogeneous condition with variable estimates of survival. Contemporary criteria for the diagnosis of clinically suspected AM enable non-invasive assessment, resulting in greater sensitivity and more representative cohorts. We aimed to describe the demographic char...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannata, Antonio, Bhatti, Prashan, Roy, Roman, Al-Agil, Mohammad, Daniel, Allen, Ferone, Emma, Jordan, Antonio, Cassimon, Barbara, Bradwell, Susie, Khawaja, Abdullah, Sadler, Matthew, Shamsi, Aamir, Huntington, Josef, Birkinshaw, Alexander, Rind, Irfan, Rosmini, Stefania, Piper, Susan, Sado, Daniel, Giacca, Mauro, Shah, Ajay M., McDonagh, Theresa, Scott, Paul A., Bromage, Daniel I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606774/
https://www.ncbi.nlm.nih.gov/pubmed/36312271
http://dx.doi.org/10.3389/fcvm.2022.1037837
Descripción
Sumario:AIM: Acute myocarditis (AM) is a heterogeneous condition with variable estimates of survival. Contemporary criteria for the diagnosis of clinically suspected AM enable non-invasive assessment, resulting in greater sensitivity and more representative cohorts. We aimed to describe the demographic characteristics and long-term outcomes of patients with AM diagnosed using non-invasive criteria. METHODS AND RESULTS: A total of 199 patients with cardiac magnetic resonance (CMR)-confirmed AM were included. The majority (n = 130, 65%) were male, and the average age was 39 ± 16 years. Half of the patients were White (n = 99, 52%), with the remainder from Black and Minority Ethnic (BAME) groups. The most common clinical presentation was chest pain (n = 156, 78%), with smaller numbers presenting with breathlessness (n = 25, 13%) and arrhythmias (n = 18, 9%). Patients admitted with breathlessness were sicker and more often required inotropes, steroids, and renal replacement therapy (p < 0.001, p < 0.001, and p = 0.01, respectively). Over a median follow-up of 53 (IQR 34–76) months, 11 patients (6%) experienced an adverse outcome, defined as a composite of all-cause mortality, resuscitated cardiac arrest, and appropriate implantable cardioverter defibrillator (ICD) therapy. Patients in the arrhythmia group had a worse prognosis, with a nearly sevenfold risk of adverse events [hazard ratio (HR) 6.97; 95% confidence interval (CI) 1.87–26.00, p = 0.004]. Sex and ethnicity were not significantly associated with the outcome. CONCLUSION: AM is highly heterogeneous with an overall favourable prognosis. Three-quarters of patients with AM present with chest pain, which is associated with a benign prognosis. AM presenting with life-threatening arrhythmias is associated with a higher risk of adverse events.